Advancing PD, Improving Care
Advancing PD with Baxter
As the pioneer of peritoneal dialysis since 1960, Baxter is committed to providing ESKD patients with this life-saving therapy to maintain their lifestyle and independence while enjoying potentially better clinical outcomes at substantially lower costs.
In Malaysia, Baxter has partnered with the nephrology community for more than 35 years to advance the practice of PD through innovation and education. Our aim? To improve care for all of our PD patients.
Our latest innovation, Remote Patient Monitoring with APD, gives both patients and healthcare providers peace of mind with home PD.
Improving Care with Extraneal
The use of once-daily icodextrin solution is included in the International Society for Peritoneal Dialysis [ISPD] and UK Renal Association guidelines for PD patients with diabetes for better glycemic control.1,2,a.b.c
Low-glucose PD therapy that includes Extraneal Solution helps maintain peritoneal membrane function and facilitates achievement of fluid balance,3,4-14 which potentially could reduce cardiovascular risk.15-17
Extraneal (icodextrin) Peritoneal Dialysis (PD) may be associated with improved patient survival 18 and may extend time on therapy19,20 with potential cost savings19 compared with glucose solutions.1,21,d
Advancing PD with Innovative Digital Health Eco-System
Sharesource Adequest now integrated with the Sharesource 2-way remote patient management connectivity platform enables a seamless experience managing your PD patients.
Sharesource Adequest is a modelling application built within Sharesource, for APD and CAPD, adult & pediatric patients. Using data that is entered into the system by the clinician, it is intended to assist with:
- DEFINING Peritoneal membrane transport characteristics & Peritoneal dialysis adequacy
- MODELING Solute clearances, fluid removal and carbohydrate absorption
Empowering Patients with Early Shared Decision Making
Shared decision-making (SDM) is a collaborative and iterative process where clinicians support patients to reach a treatment decision that is suitable for their clinical condition, lifestyle and social circumstances.
To facilitate SDM in the selection of kidney replacement therapy, Baxter Malaysia’s patient education website “my.MyKidneyJourney.com” offers information on Chronic Kidney Disease, Treatment Options and Living with Dialysis, which easily allows patients to find the information they need whenever they want, wherever they are.